Efficacy and safety of fixed-ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta-analysis of randomised controlled trials.

Rui WangShuoming LuoZilin XiaoZhi-Guang Zhou

Published in: Diabetes/metabolism research and reviews (2023)

IDegLira improves better glycaemic and non-glycaemic outcomes without weight gain and/or without severe or blood glucose-confirmed hypoglycaemic episodes in T2DM. Side effects of IDegLira are mild.

Keyphrases

type diabetes
glycemic control
blood glucose
weight gain
body mass index
birth weight
weight loss
cardiovascular disease
insulin resistance
early onset
blood pressure
physical activity
drug induced
metabolic syndrome